Atuação da psicologia em unidade neonatal no contexto da pandemia da covid-19 / The work of psychology in a neonatal unit in the covid-19 pandemic / Actuación de la psicología en una unidad neonatal en el contexto de la pandemia de la covid-19

A pandemia de covid-19 provocou intensas mudanças no contexto do cuidado neonatal, exigindo dos profissionais de saúde a reformulação de práticas e o desenvolvimento de novas estratégias para a manutenção da atenção integral e humanizada ao recém-nascido. O objetivo deste artigo é relatar a atuação da Psicologia nas Unidades Neonatais de um hospital público de Fortaleza (CE), Brasil, durante o período de distanciamento físico da pandemia de covid-19. Trata-se de estudo descritivo, do tipo relato de experiência, que ocorreu no período de março a agosto de 2020. No contexto pandêmico, o serviço de Psicologia desenvolveu novas condutas assistenciais para atender às demandas emergentes do momento, como: atendimento remoto; registro e envio on-line de imagens do recém-nascido a seus familiares; visitas virtuais; e reprodução de mensagens de áudio da família para o neonato. Apesar dos desafios encontrados, as ações contribuíram para a manutenção do cuidado centrado no recém-nascido e sua família, o que demonstra a potencialidade do fazer psicológico.(AU)

The COVID-19 pandemic brought intense changes to neonatal care and required health professionals to reformulate practices and develop new strategies to ensure comprehensive and humanized care for newborn. This study aims to report the experience of the Psychology Service in the Neonatal Units of a public hospital in Fortaleza, in the state of Ceará, Brazil, during the social distancing period of the COVID-19 pandemic. This descriptive experience report study was conducted from March to August 2020. During the pandemic, the Psychology Service developed new care practices to meet the emerging demands of that moment, such as remote care, recordings and online submission of newborns' pictures and video images for their family, virtual tours, and reproduction of family audio messages for the newborns. Despite the challenges, the actions contributed to the maintenance of a care that is centered on the newborns and their families, which shows the potential of psychological practices.(AU)

La pandemia de la COVID-19 ha traído cambios intensos en el contexto de la atención neonatal, que requieren de los profesionales de la salud una reformulación de sus prácticas y el desarrollo de nuevas estrategias para asegurar una atención integral y humanizada al recién nacido. El objetivo de este artículo es reportar la experiencia del Servicio de Psicología en las Unidades Neonatales de un hospital público de Fortaleza, en Ceará, Brasil, durante el periodo de distanciamiento físico en la pandemia de la COVID-19. Se trata de un estudio descriptivo, un reporte de experiencia, que se llevó a cabo de marzo a agosto de 2020. En el contexto pandémico, el servicio de Psicología desarrolló nuevas conductas asistenciales para atender a las demandas emergentes del momento, tales como: atención remota; grabación y envío em línea de imágenes del recién nacido; visitas virtuales; y reproducción de mensajes de audio de la familia para el recién nacido. A pesar de los desafíos encontrados, las acciones contribuyeron al mantenimiento de la atención centrada en el recién nacido y su familia, lo que demuestra el potencial de la práctica psicológica.(AU)

The Effect of Continuous Positive Airway Pressure on Basal Metabolism Rate in Patients with Severe Obstructive Sleep Apnoea Syndrome

ABSTRACT Objective: To assess the effect of the continuous positive airway pressure (CPAP) treatment on basal metabolism rate (BMR) in patients with severe obstructive sleep apnoea syndrome (OSAS). Methods: Demographic characteristics, body mass index (BMI), apnoea-hypopnoea index (AHI) and smoking history of the patients were recorded. Basal metabolism rate was measured via indirect calorimetry in the morning following nights of polysomnography and CPAP titration. Basal metabolism rate, oxygen consumption (VO2) and carbon dioxide output (VCO2) levels were compared before and after CPAP administration. Results: A total of 25 patients with a mean age of 51.4 ± 13.7 years were included in the study: 6 (24%) female and 19 (76%) male. A significant reduction in the BMR (p = 0.049), VO2 (p = 0.042) and VCO2 (p = 0.008) values were observed after a single night administration of CPAP as compared to before treatment. Furthermore, it was detected that this reduction provided by CPAP treatment was more significant in current smokers, patients with AHI > 60 and BMI ≥ 30. Conclusion: It is suggested that there is a correlation between BMR and the severity of OSAS, and it is possible to provide a significant reduction in BMR with single night administration of CPAP depending on the patient's smoking history, degree of obesity and disease severity.

Autoeficacia percibida y adherencia al CPAP (presión positiva continua en la vía aérea) en personas con apnea del sueño / Perceived self-efficacy and adherence to CPAP (continuous positive airway pressure) in people with sleep apnea

Objetivo: Determinar la relación entre la autoeficacia percibida y la adherencia objetiva al CPAP en una población de pacientes con SAHOS de una institución especializada en cuidado respiratorio de la ciudad de Bogotá. Método: Se utilizó un diseño de corte transversal con abordaje cuantitativo - correlacional, a partir de una corte de pacientes con Síndrome de Apnea Obstructiva del Sueño (SAHOS) moderado o severo. Entre los meses de septiembre y noviembre de 2018, se incluyeron de forma consecutiva 136 pacientes, hombres y mujeres, mayores de edad, que usaban CPAP y asistieron a consulta de neumología, sueño, rehabilitación y exámenes diagnósticos. Se obtuvo información demográfica y clínica. Cada participante diligenció el instrumento SEMSA para evaluar la autoeficacia y se obtuvo lectura de tarjeta del dispositivo, para evaluar adherencia objetiva. Se analizaron los datos por medio de un modelo de regresión logística. Resultados y conclusiones: La correlación entre la autoeficacia y la adherencia objetiva al CPAP, mostró un coeficiente de Sperman -,076. En el análisis discriminado, la dimensión autoeficacia de la escala de autoeficacia, mostró una correlación débil (Rho Sperman=0.17) estadísticamente significativa (p=0.048), lo cual concuerda con lo reportado en algunas publicaciones hechas en poblaciones diferentes a la estudiada. La puntuación de la dimensión de autoeficacia (3,4/4) fue superior a lo informado en la literatura, y la de expectativas de riesgo (1,85/4) fue inferior a lo reportado. Los pacientes jóvenes tuvieron una mayor autoeficacia que las personas mayores. La adherencia objetiva al CPAP (uso de CPAP > a 4 horas/noche por más del 70% de las noches) fue del 66,9 % con un promedio de horas de uso por noche de 5,54, valores más altos que los reportados a nivel mundial y local. Otras variables no tuvieron asociación con la adherencia.

Objective: To determine the relationship between perceived self-efficacy and objective adherence to CPAP in a population of patients with OSAHS from an institution specialized in respiratory care in the city of Bogotá. Method: This is a cross-sectional design with a quantitative-correlational approach, based on a cut-off of patients with moderate or severe obstructive sleep apnea OSAHS. Between the months of September and November of 2018, 136 patients were included; both gender male and female, which were above legal age 18 years old, users of CPAP machine and who attended to the pulmonology consultation, sleep, rehabilitation and diagnostic tests. Demographic and clinical information was obtained. Each participant completed the instrument in order to evaluate self-efficacy. Also, to evaluate objective adherence, card reading of the CPAP device, was obtained. The data was analyzed by logistic regression model. Results and conclusions: The correlation between self-efficacy and objective adherence to CPAP showed a Sperman coefficient of -,076. In the discriminated analysis, the selfefficacy dimension of the self-efficacy scale showed a weak correlation (Rho Spermean = 0.17) statistically significant (p = 0.048), in the sense that the information is relevant. The score of the dimension of self-efficacy (3.4 / 4) was higher and reported in the literature, but lower in the domain of risk expectations (1.85 / 4). Young patients had greater self-efficacy than older patients. Objective adherence to CPAP (use of CPAP> at 4 hours / night for more than 70% of the nights) was 66.9% with an average nighttime usage of 5.54, higher values than those reported Globally and locally. Other variables had no association with adherence.

Effect of prophylactic non-invasive mechanical ventilation on functional capacity after heart valve replacement: a clinical trial

OBJECTIVE: During cardiac surgery, several factors contribute to the development of postoperative pulmonary complications. Non-invasive ventilation is a promising therapeutic tool for improving the functionality of this type of patient. The aim of this study is to evaluate the functional capacity and length of stay of patients in a nosocomial intensive care unit who underwent prophylactic non-invasive ventilation after heart valve replacement. METHOD: The study was a controlled clinical trial, comprising 50 individuals of both sexes who were allocated by randomization into two groups with 25 patients in each group: the control group and experimental group. After surgery, the patients were transferred to the intensive care unit and then participated in standard physical therapy, which was provided to the experimental group after 3 applications of non-invasive ventilation within the first 26 hours after extubation. For non-invasive ventilation, the positive pressure was 10 cm H2O, with a duration of 1 hour. The evaluation was performed on the 7th postoperative day/discharge and included a 6-minute walk test. The intensive care unit and hospitalization times were monitored in both groups. Brazilian Registry of Clinical Trials (REBeC): RBR number 8bxdd3. RESULTS: Analysis of the 6-minute walk test showed that the control group walked an average distance of 264.34±76 meters and the experimental group walked an average distance of 334.07±71 meters (p=0.002). The intensive care unit and hospitalization times did not differ between the groups. CONCLUSION: Non-invasive ventilation as a therapeutic resource was effective toward improving functionality; however, non-invasive ventilation did not influence the intensive care unit or hospitalization times of the studied cardiac patients.

Predictors of success for mandibular repositioning appliance in obstructive sleep apnea syndrome

Abstract The characteristics of non-obese patients with mild to moderate Obstructive Sleep Apnea Syndrome (OSAS) who will present with a good response to Mandibular Repositioning Appliance (MRA) treatment have not yet been well established in the literature. The aim of this study is to assess whether polysomnographic (PSG), demographic, anthropometric, cephalometric, and otorhinolaryngological parameters predict MRA success in the treatment of OSAS. Forty (40) males with mild and moderate OSAS were assessed pretreatment and 2-months post-treatment after wearing an MRA. Demographic, anthropometric, otorhinolaryngological (ENT), cephalometric, and polysomnographic parameters, including continuous positive airway pressure (CPAP) titrated pressure, dental models, Epworth Sleepiness Scale, quality of life (Short Form SF-36), and mood state (Profile of Mood States – POMS), were assessed. The responders exhibited fewer oropharyngeal alterations, increased upper pharyngeal space, reduced lower airway space, and increased mandibular intercanine width, and they had milder disease. Nevertheless, no predictive factors of MRA success could be found. MRA was more successful among men with a more pervious airway, a larger interdental width and milder OSAS. However, a combined [1] functional and structural assessment is needed to successfully predict the [2] effectiveness of MRA treatment of OSA.

Bilateral parotitis in a patient under continuous positive airway pressure treatment / Parotidite bilateral em paciente sob tratamento com pressão positiva contínua das vias aéreas

Abstract Background and objectives: Many conditions such as bacterial and viral infectious diseases, mechanical obstruction due to air and calculi and drugs can cause parotitis. We present a case of unusual bilateral parotitis in a patient under non-invasive continuous positive airway pressure (CPAP) therapy for chronic obstructive pulmonary disease exacerbation in intensive care unit. Case report: A 36-year-old patient was admitted to intensive care unit with the diagnosis of chronic obstructive pulmonary disease exacerbation. Antibiotherapy, bronchodilator therapy and non-invasive positive pressure ventilation were applied as treatment regimen. Painless swellings developed on the 3rd day of admission on the right and a day after this on the left parotid glands. Amylase levels were increased and ultrasonographic evaluation revealed bilateral parotitis. No intervention was made and the therapy was continued. The patient was discharged on the 6th day with clinical improvement and regression of parotid swellings without any complications. Conclusions: Parotitis may have occurred after retrograde air flow in the Stensen duct during CPAP application. After the exclusion of possible viral and bacteriological etiologies and possible drug reactions we can focus on this diagnosis.

Resumo Justificativa e objetivos: Muitas condições podem causar parotidite, incluindo doenças infecciosas virais e bacterianas, obstrução mecânica por causa da presença de ar, cálculos e medicamentos. Apresentamos um caso de parotidite bilateral incomum em um paciente sob tratamento com pressão positiva contínua não invasiva das vias aéreas (PPCVA) para exacerbação da doença pulmonar obstrutiva crônica em unidade de terapia intensiva. Relato de caso: Paciente de 36 anos, internado em unidade de terapia intensiva com diagnóstico de exacerbação da doença pulmonar obstrutiva crônica. Antibioterapia, terapia broncodilatadora e ventilação com pressão positiva não invasiva foram aplicadas como regime de tratamento. No terceiro dia de internação, inchaços indolores desenvolveram‐se à direita da glândula parótida e, depois, à esquerda. Os níveis de amilase aumentaram e o exame ultrassonográfico revelou parotidite bilateral. Nenhuma intervenção foi feita e o tratamento foi continuado. O paciente recebeu alta no sexto dia, com melhoria clínica e regressão do inchaço da parótida, sem complicações. Conclusões: A parotidite pode ter ocorrido após o fluxo retrógrado de ar do duto de Stensen durante a aplicação de PPCVA. Após a exclusão de possíveis etiologias virais e bacteriológicas e possíveis reações medicamentosas, podemos focar no diagnóstico.

Presión positiva continua en la vía aérea comparada con la respiración mecánica asistida en prematuros de 28 a 32 semanas de gestación con administración precoz de surfactante pulmonar / Nasal CPAP versus mechanical ventilation in 28 to 32-week preterm infants with early surfactant administration

Introducción. La presión positiva continua en la vía aérea ( Continuous Positive Airway Pressure , CPAP) es útil en prematuros de 28 a 32 semanas de gestación con síndrome de dificultad respiratoria, pero no se ha precisado si es mejor que la respiración mecánica asistida después de la administración precoz de surfactante pulmonar. Objetivo. Comparar la incidencia de eventos adversos en prematuros de 28 a 32 semanas de gestación con síndrome de dificultad respiratoria atendidos con surfactante y respiración mecánica asistida o CPAP de burbuja. Materiales y métodos. Se atendieron 147 neonatos con respiración mecánica asistida y 176 con CPAP, ninguno de los cuales presentaba asfixia perinatal o apnea. Resultados. La incidencia de fracaso de la CPAP fue de 6,5 % (IC 95% 11,3-22,8 %). Fallecieron 29 pacientes, 7 de los cuales habían recibido CPAP (4,0 %) y, 22, respiración mecánica asistida (15,0 %; p<0,001). El riesgo relativo (RR) de morir de quienes recibieron CPAP, comparado con el de quienes recibieron respiración mecánica asistida, fue de 0,27 (IC 95% 0,12-0,61), pero, al ajustar por los factores de confusión, el uso de CPAP no implicó mayor riesgo de morir (RR=0,60; IC 95% 0,29-1,24). La letalidad con respiración mecánica asistida fue de 5,70 (IC 95% 3,75-8,66) muertes por 1.000 días-paciente, mientras que con CPAP fue de 1,37 (IC 95% 0,65-2,88; p<0,001). La incidencia de neumopatía crónica fue menor con CPAP (RR=0,71, IC 95% 0,54-0,96), al igual que la de hemorragia cerebral (RR=0,28; IC 95% 0,09-0,84) y la de sepsis (RR=0,67; IC 95% 0,52-0,86), pero fue similar en cuanto a escapes de aire (RR=2,51; IC 95% 0,83-7,61) y enterocolitis necrosante (RR=1,68; IC 95% 0,59-4,81). Conclusión. La incidencia de neumopatía crónica, hemorragia ventricular y sepsis es menor con el uso de CPAP.

Introduction: Continuous positive airway pressure (CPAP) is useful in low birth weight infants with respiratory distress, but it is not known if it is a better alternative to mechanical ventilation after early pulmonary surfactant administration. Objective: To compare the incidence of adverse events in 28 to 32-week newborns with respiratory distress managed with mechanical ventilation or CPAP after early surfactant administration. Materials and methods: In total, 176 newborns were treated with CPAP and 147 with mechanical ventilation, all with Apgar scores >3 at five minutes and without apnea. Results: The incidence of CPAP failure was 6.5% (95% CI: 11.3-22.8%); 29 patients died: 7 with CPAP (4.0%) and 22 with mechanical ventilation (15.0%, p<0.001). The relative risk of dying with CPAP versus mechanical ventilation was 0.27 (95% CI: 0.12-0.61), but after adjusting for confounding factors, CPAP use did not imply a higher risk of dying (RR=0.60; 95% CI: 0.29-1.24). Mechanical ventilation fatality rate was 5.70 (95% CI: 3.75-8.66) deaths/1,000 days-patient, while with CPAP it was 1.37 (95% CI: 0.65-2.88, p<0.001). Chronic lung disease incidence was lower with CPAP than with mechanical ventilation (RR=0.71; 95% CI: 0.54-0.96), as were intracranial hemorrhage (RR=0.28, 95% CI: 0.09-0.84) and sepsis (RR=0.67; 95%CI: 0.52-0.86), and it was similar for air leaks (RR=2.51; 95% CI: 0.83-7.61) and necrotizing enterocolitis (RR=1.68, 95% CI: 0.59-4.81). Conclusion: CPAP exposure of premature infants with respiratory distress syndrome is protective against chronic lung disease, intraventricular hemorrhage and sepsis compared to mechanical ventilation. No differences were observed regarding air leak syndrome or death.

Impact of CPAP on physical exercise tolerance and sympathetic-vagal balance in patients with chronic heart failure / Impacto da CPAP sobre a tolerância ao exercício físico e a modulação simpatovagal de pacientes com insuficiência cardíaca crônica

Background: Chronic heart failure (CHF) leads to exercise intolerance. However, non-invasive ventilation is able to improve functional capacity of patients with CHF. Objectives: The aim of this study was to evaluate the effectiveness of continuous positive airway pressure (CPAP) on physical exercise tolerance and heart rate variability (HRV) in patients with CHF. Method : Seven men with CHF (62±8 years) and left ventricle ejection fraction of 41±8% were submitted to an incremental symptom-limited exercise test (IT) on the cicloergometer. On separate days, patients were randomized to perform four constant work rate exercise tests to maximal tolerance with and without CPAP (5 cmH2O) in the following conditions: i) at 50% of peak work rate of IT; and ii) at 75% of peak work rate of IT. At rest and during these conditions, instantaneous heart rate (HR) was recorded using a cardiofrequencimeter and HRV was analyzed in time domain (SDNN and RMSSD indexes). For statistical procedures, Wilcoxon test or Kruskall-Wallis test with Dunn's post-hoc were used accordingly. In addition, categorical variables were analysed through Fischer's test (p<0.05). Results: There were significant improvements in exercise tolerance at 75% of peak work rate of IT with CPAP (405±52 vs. 438±58 s). RMSSD indexes were lower during exercise tests compared to CPAP at rest and with 50% of peak work rate of IT. Conclusion: These data suggest that CPAP appears to be a useful strategy to improve functional capacity in patients with CHF. However, the positive impact of CPAP did not generate significant changes in the HRV during physical exercises. .

Contextualização: A insuficiência cardíaca (IC) crônica cursa com intolerância ao exercício físico. A ventilação não invasiva (VNI) tem se mostrado benéfica para a melhora da performance desses pacientes. Objetivos: Avaliar a eficiência da pressão positiva contínua nas vias aéreas (CPAP) sobre a tolerância ao exercício físico e a variabilidade da frequência cardíaca (VFC) de pacientes com IC crônica. Método: Sete homens com IC crônica (62±8 anos) e fração de ejeção do ventrículo esquerdo de 41±8% foram submetidos ao teste incremental (TI) sintoma-limitado em cicloergômetro. Posteriormente, foram aleatorizados para a realização de exercícios físicos de carga constante até a tolerância máxima com e sem CPAP (5 cmH2O) nas condições: i) 50% da carga pico do TI e ii) 75% da carga pico do TI. Em repouso e durante os testes, a frequência cardíaca (FC) instantânea foi obtida pelo cardiofrequencímetro, e a VFC foi analisada no domínio do tempo. A análise estatística foi realizada pelos testes de Wilcoxon ou Kruskall-Wallis com post-hoc de Dunn e as variáveis categóricas, pelo teste de Fischer (p<0,05). Resultados: Durante a CPAP, houve aumento significativo no tempo de exercício físico (405±52 vs. 438±58 s) e da FC pico (97±3 vs. 105±2 bpm) somente na intensidade de 75%. Em relação à VFC, observou-se que o RMSSD foi significativamente menor em exercício físico quando comparado ao repouso com CPAP na intensidade 50%. Conclusão: Em conclusão, a CPAP com 5 cmH20 mostrou-se um útil na melhora da capacidade funcional dos pacientes estudados com pouco impacto sobre a VFC. .

Adesão de pacientes com síndrome da apneia obstrutiva do sono à pressão positiva contínua em via aérea em um serviço público / Adherence of obstructive sleep apnea syndrome patients to continuous positive airway pressure in a public service

Introdução: A terapia padrão para tratamento da síndrome da apneia obstrutiva do sono (SAOS) é o aparelho de pressão positiva contínua em via aérea (CPAP); todavia, seu uso correto e frequente é determinante para o controle da doença. Objetivo: Analisar a adesão ao CPAP entre pacientes com SAOS tratados em um ambulatório multidisciplinar em um hospital público. Métodos: Estudo retrospectivo avaliando 156 pacientes com SAOS que foram submetidos à polissonografia para titulação de CPAP de 2008 a 2011. Os pacientes foram divididos em dois grupos: os com boa e os com má adesão. Os grupos foram comparados entre si em relação aos seus dados: sexo, idade, IMC, doenças associadas, IAH à polissonografia diagnóstica e pressão em (cmH20) sugerida à polissonografia de titulação. Resultados: Foram analisados 125 pacientes, demonstrando que 82 dels (65%) tinham boa adesão, enquanto 43 (35%) eram maus usuários. A comparação entre os grupos mostrou que os pacientes com maior índice de apneia e hipopneias (IAH) eram os com melhor adesão ao tratamento com CPAP. Conclusões: A taxa de adesão ao CPAP entre os pacientes com SAOS monitorizados regularmente em um serviço público foi de 65%. Os pacientes com pior IAH foram os mais aderentes ao tratamento com CPAP. .

Introduction: The standard therapy for obstructive sleep apnea syndrome (OSAS) is continuous positive airway pressure (CPAP), but its correct and frequent use is essential to control the disease. Purpose: To analyze adherence to CPAP among patients with OSAS treated in a multidisciplinary outpatient clinic of a public tertiary hospital. Methods: This was a retrospective study evaluating 156 patients with OSAS who underwent polysomnography for CPAP titration from 2008 to 2011. The patients were divided into two groups, those with good adherence to CPAP (a mean use of four or more hours per night) and those with poor adherence. The groups were compared regarding the following data: gender, age, body mass index, associated diseases, AHI at diagnostic polysomnography, and pressure (cmH2O) suggested by titration polysomnography. Results: 125 patients were analyzed, and it was observed that 82 of the patients (65%) had good adherence, whereas 43 (35%) showed poor adherence. Comparison between groups revealed that patients with a higher apnea-hypopnea index (AHI) were those who better adhered to treatment with CPAP. Conclusions: the rate of adherence to CPAP among OSAS patients undergoing clinical monitoring at a public service was 65%. Patients with a higher AHI were those who adhered better to treatment with CPAP. .

Efeito Agudo da Pressao Positiva Continua sobre a Pressao de Pulso na Insuficiencia Cardiaca Cronica / Acute Effects of Continuous Positive Air way Pressure on Pulse Pressure in Chronic Heart Failure

Fundamento: Pacientes com insuficiência cardíaca (IC) apresentam disfunção ventricular esquerda e redução da pressão arterial média (PAM). O aumento do estímulo adrenérgico causa vasoconstrição e resistência dos vasos, mantendo a PAM, enquanto aumenta a resistência vascular periférica e a rigidez dos vasos condutores. O aumento da pressão de pulso (PP) reflete a complexa interação do coração com os sistemas arteriais e venosos. O aumento da PP é um importante marcador de risco em pacientes com insuficiência cardíaca crônica (ICC). A ventilação não invasiva (VNI) tem sido utilizada para IC aguda descompensada para melhorar a congestão e a ventilação pelos efeitos respiratórios e hemodinâmicos. No entanto, nenhum desses estudos relatou o efeito da VNI na PP. Objetivo: O objetivo deste estudo foi determinar os efeitos agudos da VNI com CPAP (pressão positiva contínua nas vias aéreas) sobre a PP em pacientes ambulatoriais com ICC. Métodos: Seguindo um protocolo randomizado, duplo-cego, cruzado e controlado com placebo, 23 pacientes com ICC (17 homens, 60 ± 11 anos, IMC 29 ± 5 kg/cm2, classes II e III da NYHA) foram submetidos à CPAP via máscara nasal durante 30 minutos na posição reclinada. A pressão da máscara foi de 6 cmH2O, enquanto o placebo foi fixado em 0-1 cmH2O. PP e outras variáveis hemodinâmicas não invasivas foram avaliadas antes, durante e depois do placebo e do modo CPAP. Resultados: A CPAP diminuiu a frequência cardíaca de repouso (pré: 72 ± 9; pós 5 min: 67 ± 10 bpm , p < 0,01) e PAM (CPAP: 87 ± 11; controle 96 ± 11 mmHg , p < 0,05 pós 5 min). A CPAP diminuiu a PP (CPAP: 47 ± 20 pré para 38 ± 19 mmHg pós; controle: ...

Background: Patients with heart failure (HF) have left ventricular dysfunction and reduced mean arterial pressure (MAP). Increased adrenergic drive causes vasoconstriction and vessel resistance maintaining MAP, while increasing peripheral vascular resistance and conduit vessel stiffness. Increased pulse pressure (PP) reflects a complex interaction of the heart with the arterial and venous systems. Increased PP is an important risk marker in patients with chronic HF (CHF). Non-invasive ventilation (NIV) has been used for acute decompensated HF, to improve congestion and ventilation through both respiratory and hemodynamic effects. However, none of these studies have reported the effect of NIV on PP. Objective: The objective of this study was to determine the acute effects of NIV with CPAP on PP in outpatients with CHF. Methods: Following a double-blind, randomized, cross-over, and placebo-controlled protocol, twenty three patients with CHF (17 males; 60 ± 11 years; BMI 29 ± 5 kg/cm2, NYHA class II, III) underwent CPAP via nasal mask for 30 min in a recumbent position. Mask pressure was 6 cmH2O, whereas placebo was fixed at 0-1 cmH2O. PP and other non invasive hemodynamics variables were assessed before, during and after placebo and CPAP mode. Results: CPAP decreased resting heart rate (Pre: 72 ± 9; vs. Post 5 min: 67 ± 10 bpm; p < 0.01) and MAP (CPAP: 87 ± 11; vs. control 96 ± 11 mmHg; p < 0.05 post 5 min). CPAP decreased PP (CPAP: 47 ± 20 pre to 38 ± 19 mmHg post; vs. control: 42 ± 12 mmHg, pre to 41 ± 18 post p < 0.05 post 5 min). Conclusion: NIV with CPAP decreased pulse pressure in patients with stable CHF. Future clinical trials should investigate whether this effect is associated with improved clinical outcome. .

Diastolic function and functional capacity after a single session of continuous positive airway pressure in patients with compensated heart failure

OBJECTIVE: The effects of acute continuous positive airway pressure therapy on left ventricular diastolic function and functional capacity in patients with compensated systolic heart failure remain unclear. METHODS: This randomized, double-blind, placebo-controlled clinical trial included 43 patients with heart failure and a left ventricular ejection fraction <0.50 who were in functional classes I-III according to the New York Heart Association criteria. Twenty-three patients were assigned to continuous positive airway pressure therapy (10 cmH2O), while 20 patients received placebo with null pressure for 30 minutes. All patients underwent a 6-minute walk test (6MWT) and Doppler echocardiography before and immediately after intervention. Clinicaltrials.gov: NCT01088854. RESULTS: The groups had similar clinical and echocardiographic baseline variables. Variation in the diastolic function index (e′) after intervention was associated with differences in the distance walked in both groups. However, in the continuous positive airway pressure group, this difference was greater (continuous positive airway pressure group: Δ6MWT = 9.44+16.05×Δe′, p = 0.002; sham group: Δ6MWT = 7.49+5.38×Δe′; p = 0.015). There was a statistically significant interaction between e′ index variation and continuous positive airway pressure for the improvement of functional capacity (p = 0.020). CONCLUSIONS: Continuous positive airway pressure does not acurately change the echocardiographic indexes of left ventricle systolic or diastolic function in patients with compensated systolic heart failure. However, 30-minute continuous positive airway pressure therapy appears to have an effect on left ventricular diastolic function by increasing functional capacity. .

Modificação da via aérea superior com uso de CPAP: avaliação por faringometria acústica em apnéicos graves e roncadores simples / Upper airway reconfiguration with CPAP: acoustic pharyngometry evaluation in severe apneics and simple snorers

Introdução: A Apneia Obstrutiva do Sono (AOS) é uma doença crônica e evolutiva que tem uma alta prevalência e pode acarretar graves repercussões hemodinâmicas, neurológicas e comportamentais. A pressão positiva contínua na via aérea (CPAP) é altamente eficaz no tratamento da AOS, porém o processo de expansão da faringe por este dispositivo não é totalmente entendido. A faringometria acústica (FA) é um método de mensuração das dimensões da cavidade oral e da faringe, reprodutível e fácil de efetuar, podendo avaliar eficientemente os efeitos do CPAP na faringe e trazer informações sobre sua complacência e sítios de obstrução. Objetivo: avaliar as mudanças induzidas pelo CPAP nas dimensões da faringe e no posicionamento do palato mole em pacientes com AOS e verificar se a deformabilidade da via aérea superior pelo CPAP é maior em apneicos graves do que em roncadores simples. Desenho do estudo: estudo prospectivo. Métodos: 48 pacientes foram submetidos a FA durante o uso do CPAP. 29 pacientes com índice de apneia e hipopneia (IAH) >30 e indicação de uso do CPAP foram inclusos no grupo AOS, e 19 pacientes com IAH <=5 foram inclusos no grupo controle. Os critérios de inclusão foram: idade entre 18 e 65 anos, ambos os sexos, polissonografia (PSG) previamente realizada, e PSG para titulação do CPAP no grupo AOS. Os critérios de exclusão foram: obstrução nasal crônica pré existente, uso de medicamentos psiquiátricos, neurológicos ou miorrelaxantes, insuficiência cardíaca congestiva, índice de massa corpórea >= 35 e cirurgia palatal prévia para AOS. Os gráficos resultantes dos exames de FA foram analisados por 2 examinadores cegos que marcaram os pontos para obtenção da distância da transição orofaríngea da glote. Foram calculados também o comprimento e o volume da faringe pelo programa do aparelho. Foi então feita a análise estatística para comparar as medidas em diferentes pressões intragrupo e intergrupo. Resultados: As medidas dos dois examinadores mostraram...

Rationale: Obstructive Sleep Apnea (OSA) is an evolutive disease, with a high prevalence, that can cause serious hemodynamic, neurological and behavioral repercussions. Continuous positive airway pressure (CPAP) is highly effective in OSA treatment, however the pharynx expansion by this advice is not fully understood. Acoustic pharyngometry (AP) is a measurement method of oral cavity and pharynx dimensions, and can efficiently evaluate CPAP effects on pharynx, bringing informations about its compliance and sites of obstruction. Objectives/Hypothesis: To verify if the CPAP-induced deformability on the pharynx and soft palate is greater in obstructive sleep apnea (OSA) patients than in simple snorers. Study Design: Prospective study. Methods: 29 patients with severe OSA and 19 simple snorers underwent acoustic pharyngometry measurements while awake in supine position. Measurements were first made without CPAP, and then with a nasal CPAP starting with 4cmH2O and up to 10cmH2O. The oropharyngeal transition and the position of the glottis were marked in the generated curves by two blinded examiners. The marked values were averaged to calculate the oropharyngeal transition and the pharyngeal length and volume under zero, 4 and 10cmH2O of CPAP for each group. Results: CPAP did not produce any significant enlargement in the pharyngeal airway nor changed the soft palate positioning in both groups. At baseline, OSA patients have a longer pharynx than simple snorers. After the application of CPAP, there was no difference in the length and volume of the pharynx between groups. Conclusions: There were no significant differences in the position of oropharyngeal junction and glottis between snorers and apneics with CPAP appliance. There was no significant expansion in pharyngeal airway with CPAP appliance in snorers and apneics. Anatomically, apneics presented a longer superior airway than simple snorers.

Continuous positive airway pressure (CPAP) after lung resection: a randomized clinical trial / Pressao positiva continua nas vias aereas (CPAP) apos resseccao pulmonar: ensaio clinico randomizado

CONTEXT AND OBJECTIVE: Noninvasive mechanical ventilation during the postoperative period (PO) following lung resection can restore residual functional capacity, improve oxygenation and spare the inspiratory muscles. The objective of this study was to assess the efficacy of continuous positive airway pressure (CPAP) associated with physiotherapy, compared with physiotherapy alone after lung resection. DESIGN AND SETTING: Open randomized clinical trial conducted in the clinical hospital of Universidade Estadual de Campinas. METHOD: Sessions were held in the immediate postoperative period (POi) and on the first and second postoperative days (PO1 and PO2), and the patients were reassessed on the discharge day. CPAP was applied for two hours and the pressure adjustment was set between 7 and 8.5 cmH2O. The oxygenation index (OI), Borg scale, pain scale and presence of thoracic drains and air losses were evaluated. RESULTS : There was a significant increase in the OI in the CPAP group in the POi compared to the Chest Physiotherapy (CP) group, P = 0.024. In the CP group the OI was significantly lower on PO1 (P = 0,042), than CPAP group. The air losses were significantly greater in the CPAP group in the POi and on PO1 (P = 0.001, P = 0.028), but there was no significant difference between the groups on PO2 and PO3. There was a statistically significant difference between the groups regarding the Borg scale in the POi (P < 0.001), but there were no statistically significant differences between the groups regarding the pain score. CONCLUSION: CPAP after lung resection is safe and improves oxygenation, without increasing the air losses through the drains. CLINICAL TRIAL REGISTRATION: NCT01285648 .

CONTEXTO E OBJETIVO: A ventilação mecânica não invasiva no período pós-operatório (PO) de ressecção pulmonar pode restaurar a capacidade residual funcional, melhorar a oxigenação e poupar os músculos inspiratórios. O objetivo deste estudo foi avaliar a eficácia da CPAP associada à fisioterapia comparada à fisioterapia unicamente após ressecção pulmonar. ESTUDO E LOCAL: Ensaio clínico randomizado aberto, realizado no Hospital das Clínicas da Universidade Estadual de Campinas. MÉTODO: Os atendimentos foram realizados nos PO imediato (POi), primeiro e segundo (PO1, PO2) dias, e a reavaliação na alta hospitalar. A CPAP foi aplicada durante duas horas e o ajuste pressórico estabelecido entre 7 e 8,5 cmH2O. Foram analisados índice de oxigenação (IO), escala de Borg e de dor, presença e perda aérea dos drenos torácicos. RESULTADOS: No grupo CPAP ocorreu aumento significativo do IO no POi (P = 0,024), comparado com o grupo fisioterapia respiratória. Houve redução significativa do IO no PO1 (P = 0,042) para o grupo fisioterapia respiratória, comparando-se à CPAP. A perda aérea foi significativamente maior para o grupo CPAP no POi e PO1 (0,001; 0,028), mas nos PO2 e no PO3 não houve diferença significativa entre os grupos. Foi verificada diferença significativa entre os grupos para a escala de Borg no POi (P < 0,001), porém para a escala de dor não foram verificadas diferenças significativas entre os grupos. CONCLUSÃO: A CPAP após ressecção pulmonar é segura e melhora a oxigenação sem aumentar a perda aérea pelos drenos. REGISTRO DE ENSAIO CLÍNICO: NCT01285648 .

Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels

OBJECTIVE: To investigate the effect of obstructive sleep apnea and continuous positive airway pressure treatment on serum butyrylcholinesterase activity and ischemia-modified albumin levels. METHODS: Thirty-two patients with obstructive sleep apnea and 30 age- and sex-matched controls were enrolled and underwent a diagnostic polysomnogram. The serum butyrylcholinesterase activity, ischemia-modified albumin levels, metabolic parameters, and polysomnography scores were detected and evaluated. Nine patients were studied before and after treatment with continuous positive airway pressure. RESULTS: The serum ischemia-modified albumin levels were significantly higher and the butyrylcholinesterase activity was significantly lower in patients with obstructive sleep apnea than in the controls (p<0.001). The continuous positive airway pressure treatment decreased the modified albumin levels and elevated the buthrylcholinesterase activity (p = 0.019 and p = 0.023, respectively). The modified albumin levels were positively correlated with the apnea-hypopnea index (r = 0.462, p = 0.008) at baseline. Elevated ischemia-modified albumin levels can be more accurate than butyrylcholinesterase activity at reflecting the presence of obstructive sleep apnea. Receiver operating characteristic curves revealed a significant difference between the areas under the curve 0.916 for ischemia-modified albumin and 0.777 for butyrylcholinesterase (z = 2.154, p = 0.031). CONCLUSION: The elevated ischemia-modified albumin level was significantly associated with obstructive sleep apnea and was more sensitive than butyrylcholinesterase activity in reflecting obstructive sleep apnea. The continuous positive airway pressure treatment helped to ameliorate the imbalance. .

Oxidative stress and quality of life in elderly patients with obstructive sleep apnea syndrome: are there differences after six months of Continuous Positive Airway Pressure treatment?

OBJECTIVES: This study evaluated the effect of Continuous Positive Airway Pressure treatment on oxidative stress parameters and the quality of life of elderly patients with obstructive sleep apnea syndrome. METHODS: In total, 30 obstructive sleep apnea syndrome patients and 27 subjects without obstructive sleep apnea syndrome were included in this study. Both groups underwent quality of life and oxidative stress evaluations at baseline and after six months. Polysomnography was performed in both groups at baseline and a second time in the obstructive sleep apnea syndrome group after six months of Continuous Positive Airway Pressure treatment. All of the variables were compared between the control and obstructive sleep apnea syndrome groups in this prospective case-control study. RESULTS: The baseline concentrations of the antioxidant enzyme catalase were higher in the obstructive sleep apnea syndrome group than the control group. After Continuous Positive Airway Pressure treatment, the obstructive sleep apnea syndrome group exhibited a reduction in the level of oxidative stress, as indicated by a decrease in the level of lipid peroxidation measured by the malondialdehyde (MDA) concentration [pre: 2.7 nmol malondialdehyde/mL (95% 1.6-3.7) vs. post: 1.3 nmol MDA/mL (0.7-1.9), p<0.01]. Additionally, improvements were observed in two domains covered by the SF-36 questionnaire: functional capacity [pre: 77.4 (69.2-85.5) vs. post: 83.4 (76.9-89.9), p = 0.002] and pain [pre: 65.4 (52.8-78.1) vs. post: 77.8 (67.2-88.3), p = 0.004]. CONCLUSION: Our study demonstrated that the use of Continuous Positive Airway Pressure to treat obstructive sleep apnea syndrome in elderly patients reduced oxidative stress and improved the quality of life.

Incidência e principais fatores associados à falha na extubação em recém-nascidos prematuros / Incidence and key factors associated with the fail of extubation in premature newborns

Objetivos: Determinar a incidência de falha na extubação em recém-nascidos prematuros extubados, utilizando-se pressão positiva contínua nas vias aéreas nasais, e identificar os principais fatores de risco que possam estar associados à necessidade de reintubação nessa população. Métodos: Análise retrospectiva dos prontuários de pacientes internados e submetidos a ventilação mecânica invasiva posterior a extubação, utilizando-se pressão positiva contínua por cânula nasal durante o período de janeiro a dezembro de 2008. Falha na extubação foi definida como necessidade de reintubação nas primeiras 48 horas após a primeira tentativa de extubação. Resultados: Dentre os 348 pacientes estudados, 73 foram submetidos a essa tentativa de desmame, sendo que apenas 12 (16,4%) tiveram falha na extubação, e a média de horas extubadas até a reintubação foi de 7,17, com desvio padrão de 6,38. Comparando esses recém-nascidos com aqueles extubados com sucesso, observou-se correlação significativa em relação ao tempo de ventilação mecânica invasiva (p < 0,032) e tempo de internação na unidade (p < 0,028). Alguns resultados secundários também foram diferentes:dos que obtiveram falha na extubação, 67% apresentaram sepse neonatal tardia. Conclusões: O estudo demonstrou uma incidência de falha na extubação semelhante à da literatura. O principal fator de risco para falha nessa população foi o tempo de ventilação mecânica invasiva e o tempo de internação. Nesses prematuros extremos, a implementação de estratégias para extubação precoce e o uso de outros métodos de assistência ventilatória com protocolos pré e pós-extubação podem contribuir para a melhora desses resultados.

Objectives: To determine the incidence of extubation failure in preterm infants extubated using continuous positive airway pressure and to identify the main risk factors that may be associated with reintubation in this population. Methods: Retrospective analysis of medical records of patients admitted and submitted to invasive mechanical ventilation after extubation using continuous positive airway pressure by nasal cannula during the period from January to December 2008. Extubation failure was defined as the need for reintubation within 48 hours after the first attempt of extubation. Results: Among the 348 patients studied, 73 were submitted to this attempt at weaning, and only 12 (16.4%) had failed extubation; the average hours until reintubation was 7.17, with standard deviation of 6.38. Comparing these newborns with those successfully extubated, a significant correlation in relation to the time of mechanical ventilation (p < 0.032) and period of admission in the unit (p < 0.028) were observed. Some secondary outcomes were also different: of those who have failed extubation, 67% had late neonatal sepsis. Conclusions: The study showed an incidence of extubation failure similar to that found in literature. The main risk factor for failure in this population was the time of invasive mechanical ventilation and period of hospitalization. In these extremely premature infants, the implementation of strategies for early extubation and the use of other methods of assisted ventilation with pre- and post-extubation may contribute to the improvement of these results.

Efeitos da pressão positiva contínua nas vias aéreas na insuficiência cardíaca crônica / Effects of the continuous positive airway pressure on the airways of patients with chronic heart failure

FUNDAMENTO: A insuficiência cardíaca pode apresentar disfunção assintomática à descompensação, com limitações e diminuição da capacidade produtiva. A pressão positiva contínua nas vias aéreas (CPAP) é um meio não farmacológico de redução da pós-carga. OBJETIVO: Analisar os efeitos da CPAP (10 cmH2O), por 30 dias, em paciente com insuficiência cardíaca crônica. MÉTODOS: Avaliamos 10 pacientes, com diversas etiologias, idade média de 54 ± 14 anos, sexo (masc.= 6 e fem.= 4), com IMC de 21 ± 0,04 kg/m². A terapia foi ofertada por 60 min., 5 vezes por semana, durante 1 mês, no período diurno. Foram analisados ecocardiograma e ergoespirometria, antes e após 30 dias de terapia. RESULTADOS: Apresentou aumento de 19,59 por cento na fração de ejeção do ventrículo esquerdo (FEVE): 23.9 ± 8.91 vs 27.65 ± 9.56 por cento; p = 0,045. Na ergoespirometria, o tempo de exercício (Tex) apresentou aumento significante de 547 ± 151,319 vs 700 ± 293,990 seg., p = 0,02, o consumo de oxigênio (VO2) foi de 9,59 ± 6,1 vs 4,51 ± 2,67 ml.kg-1.min.-1 , p = 0,01, enquanto a produção de dióxido de carbono (VCO2) de repouso (9,85 ± 4,38 vs 6,44 ± 2,88 ml.kg-1.min.-1 , p = 0,03) apresentou diminuição. CONCLUSÃO: A CPAP provocou aumento na fração de ejeção do ventrículo esquerdo e no tempo de exercício, diminuiu o consumo de oxigênio e a produção de dióxido de carbono no repouso.

BACKGROUND: Heart failure can present with asymptomatic dysfunction at decompensation, with limitations and decrease in the productive capacity. The Continuous Positive Airway Pressure (CPAP) is a non-pharmacological means to decrease afterload. OBJECTIVE: To analyze the effects of CPAP (10 cmH2O), for 30 days in patients with chronic heart failure. METHODS: We assessed 10 patients with heart failure (6 males, 4 females) of several etiologies, with a mean age of 54 ± 14 years, with a BMI of 21 ± 0.04 kg/m². The therapy was applied for 60 min., 5 times a week for 30 days, during the daytime. The echocardiogram and the ergospirometry were analyzed, before and 30 days after the therapy. RESULTS: There was a 19.59 percent increase in the left ventricular ejection fraction (LVEF): 23.9 ± 8.91 vs 27.65 ± 9.56 percent; p = 0.045. At the ergospirometry, the exercise time (ET) showed a significant increase from 547 ± 151.319 vs 700 ± 293.990 sec., p = 0.02; oxygen consumption (VO2) was 9.59 ± 6.1 vs 4.51 ± 2.67 ml.kg-1.min.-1, p = 0.01, whereas the carbon dioxide production (VCO2) at rest (9.85 ± 4.38 vs 6.44 ± 2.88 ml.kg-1.min.-1, p = 0.03) decreased. CONCLUSION: The CPAP resulted in an increase in the LVEF and ET, decreased the oxygen consumption and the carbon dioxide production at rest.

Hipoventilação relacionada ao sono / Sleep hypoventilation

Tanto SHO como as doenças neuromusculares estão relacionadas à hipoventilação durante o sono. Define-se SHO como a combinação de obesidade, hipercapnia e hipoxemia crônica durante a vigília que se agrava durante o sono. Em 90 por cento dos casos, SHO está associada à apneia obstrutiva do sono. O diagnóstico baseia-se na presença de hipoventilação diurna e hipertensão pulmonar que não são justificadas por alterações da função pulmonar. A mortalidade dos pacientes com SHO é maior que aquela de pacientes sem hipoventilação e controlados para obesidade. As doenças neuromusculares são representadas principalmente pelas distrofias musculares. A progressão para insuficiência respiratória crônica surge como consequência da fraqueza dos músculos respiratórios e da limpeza inadequada das vias aéreas, causando atelectasias e pneumonias. Quando há uma redução maior que 50 por cento da forca muscular respiratória, ocorre uma diminuição na CV. A medida do pico de fluxo da tosse < 160 L/min está associada à limpeza inadequada das vias aéreas, e, com valores em torno de 270 L/min, há indicação de uso de técnicas de tosse assistida. A apneia obstrutiva do sono geralmente agrava a hipoventilação durante o sono. O suporte pressórico não invasivo durante a noite pode aumentar a sobrevida, melhorar os sintomas e a hipoventilação diurna. Além disso, no caso de doenças neuromusculares, pode diminuir o declínio da função pulmonar. A oxigenoterapia pode ser necessária nos casos de SHO.

Sleep hypoventilation is seen in patients with neuromuscular disease, as well as in those with obesity hypoventilation syndrome (OHS), which is defined as the combination of obesity, chronic hypercapnia, and hypoxemia during wakefulness that is aggravated during sleep. In 90 percent of cases, OHS is accompanied by obstructive sleep apnea. The diagnosis of OHS is based on hypoventilation and pulmonary hypertension that cannot be explained by alterations in pulmonary function. The mortality of patients with OHS is greater than is that of obese patients without hypoventilation. The principal neuromuscular diseases associated with OHS are the muscular dystrophies. The progression to chronic respiratory failure results from respiratory muscle weakness and impaired airway secretion clearance, causing atelectasis and pneumonia. With a decrease of greater than 50 percent in respiratory muscle strength, there is a reduction in VC. Cough peak flow < 160 L/min is associated with impaired airway secretion clearance, and values near 270 L/min indicate the need for assisted cough techniques. Obstructive sleep apnea usually worsens sleep hypoventilation. Noninvasive ventilation during sleep can improve survival, symptoms, and hypoventilation during wakefulness, as well as being able to improve pulmonary function in patients with neuromuscular disease. Patients with OHS can require oxygen therapy.

Efeito da pressão positiva contínua nas vias aéreas sobre os volumes pulmonares em portadores de doença pulmonar obstrutiva crônica / Effect of the continuous positive airway pressure over pulmonary volumes in chronic obstructive pulmonary disease

Introdução: Em pacientes com doença pulmonar obstrutiva crônica (DPOC), a ventilação não-invasiva com pressão positiva reduz o trabalho respiratório e melhora a ventilação alveolar. O objetivo do presente estudo foi avaliar os efeitos imediatos da pressão positiva contínua nas vias aéreas (CPAP) sobre os parâmetros funcionais em portadores de DPOC. Metodologia: Em um ensaio clínico não randomizado e aberto, foram avaliados 11 portadores de DPOC moderada ou grave, estáveis clinicamente. Todos os pacientes foram avaliados antes e depois da aplicação de dois diferentes níveis de CPAP (7 e 11 cmH2O). Resultados: Dos 11 pacientes estudados, 6 eram homens e 5 eram mulheres, com média de idade de 70,72 anos. A capacidade vital forçada (CVF) aumentou após a aplicação dos dois níveis de CPAP, mais acentuadamente após a CPAP de 11 cmH2O (p<0,05). Capacidade pulmonar total (CPT), capacidade residual funcional (CRF) e volume residual (VR) mostraram tendência à redução, porém sem atingir relevância estatística (p>0,05). Conclusão: A aplicação da CPAP aumenta rapidamente a CVF em pacientes portadores de DPOC.

Introduction: In patients with chronic obstructive pulmonary disease (COPD), noninvasive positive pressure ventilation reduces the work of breathing and improves alveolar ventilation. The aim of the present study was to evaluate the immediate effects of the continuous positive airway pressure (CPAP) over pulmonary volumes in chronic obstructive pulmonary disease. Methodology: This was an open, non-randomized clinical trial involving 11 clinically stable patients with COPD moderate or severe. All were evaluated before and after of the utilisation of two different level of CPAP (7 and 11 cmH2O). Results: Of the 11 patients studied, 6 were male, and 5 were female, with a mean age of 70.72 years. Forced vital capacity (FVC) increasedafter of the utilisation of two different level of CPAP, specially after CPAP of 11 cmH2O (p<0,05). Total lung capacity (TLC), functional residual capacity (FRC) and residual volume (RV) decreased, however without significant change (p>0,05). Conclusion: The utilisation of the CPAP increase quickly FVC in patients with COPD.